Literature DB >> 25059418

Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro.

André Said1, Stephanie Bock, Gerrit Müller, Günther Weindl.   

Abstract

The specific function of human skin-resident dendritic cell (DC) subsets in the regulation of immunity or tolerance is still a matter of debate. Langerhans cells (LC) induce anti-viral immune responses but, conversely to dermal DC, maintain tolerance to bacteria. However, the definite function of epidermal LC and cutaneous DC appears even more complex under inflammatory conditions. Here we investigated the immune responses of human immature monocyte-derived DC (MoDC) and LC-like cells (MoLC) upon stimulation with different Toll-like receptor ligands in the presence or absence of pro-inflammatory cytokines tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). In MoDC, bacterial antigens selectively up-regulated CD83 and CD86 expression and induced the release of T helper type 1 (Th1) and Th17 cytokines and led to a higher CCR7-dependent migratory capacity compared with a low responsiveness of MoLC. Importantly, MoLC activation with lipopolysaccharide under inflammatory conditions strongly enhanced a phenotypically mature state, increased IL-12p70, IL-23 and IL-6 production and Th1 cytokine secretion by CD4(+) T cells. Treatment with poly(I:C) specifically up-regulated surface expression of co-stimulatory molecules and increased release of IL-12p70 in MoLC and co-stimulation with TNF-α and IL-1β further elevated Th1 and Th17 cytokine production. Poly(I:C)-induced up-regulation of type I interferon mRNA levels in MoLC and MoDC was Toll-like receptor 3-dependent but not, or only weakly, modulated by pro-inflammatory cytokines. Our results indicate that inflammatory conditions greatly facilitate recognition of bacteria by MoLC. Furthermore, we suggest a critical involvement of both subsets in innate defence against viruses, whereas inflammatory skin environments additionally favour MoLC as potent inducers of Th1 and Th17 cytokines.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Langerhans cells; Toll-like receptors; dendritic cells; interleukin-1β; tumour necrosis factor-α

Mesh:

Substances:

Year:  2015        PMID: 25059418      PMCID: PMC4298416          DOI: 10.1111/imm.12363

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

Review 1.  Cutaneous dendritic cells.

Authors:  Jenny Valladeau; Sem Saeland
Journal:  Semin Immunol       Date:  2005-08       Impact factor: 11.130

Review 2.  TLR signalling and the function of dendritic cells.

Authors:  Hiroaki Hemmi; Shizuo Akira
Journal:  Chem Immunol Allergy       Date:  2005

Review 3.  Dendritic cells: understanding immunogenicity.

Authors:  Ralph M Steinman
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

4.  CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis.

Authors:  Krista Ouwehand; Saskia J A M Santegoets; Derk P Bruynzeel; Rik J Scheper; Tanja D de Gruijl; Susan Gibbs
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.

Authors:  Günther Weindl; Julian R Naglik; Susanne Kaesler; Tilo Biedermann; Bernhard Hube; Hans Christian Korting; Martin Schaller
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.

Authors:  Eynav Klechevsky; Rimpei Morita; Maochang Liu; Yanying Cao; Sebastien Coquery; Luann Thompson-Snipes; Francine Briere; Damien Chaussabel; Gerard Zurawski; A Karolina Palucka; Yoram Reiter; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

8.  Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.

Authors:  Matthias Peiser; Reinhard Wanner; Gerhard Kolde
Journal:  J Leukoc Biol       Date:  2004-06-03       Impact factor: 4.962

Review 9.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.

Authors:  Miriam Merad; Florent Ginhoux; Matthew Collin
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.

Authors:  Julien Seneschal; Xiaodong Jiang; Thomas S Kupper
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

View more
  6 in total

1.  Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells.

Authors:  Gerrit Müller; Charlotte Lübow; Günther Weindl
Journal:  Autophagy       Date:  2019-11-07       Impact factor: 16.016

2.  Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.

Authors:  M Giulbudagian; G Yealland; S Hönzke; A Edlich; B Geisendörfer; B Kleuser; S Hedtrich; M Calderón
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

3.  Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells.

Authors:  Federico Remes Lenicov; Ana Luz Paletta; Melina Gonzalez Prinz; Augusto Varese; Clara E Pavillet; Álvaro Lopez Malizia; Juan Sabatté; Jorge Raul Geffner; Ana Ceballos
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 4.  Regulation of Dendritic Cell Function in Inflammation.

Authors:  André Said; Günther Weindl
Journal:  J Immunol Res       Date:  2015-07-02       Impact factor: 4.818

5.  Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration.

Authors:  Anja Pfalzgraff; Lena Heinbockel; Qi Su; Thomas Gutsmann; Klaus Brandenburg; Günther Weindl
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

6.  Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.

Authors:  Mary-Anne Hartley; Eliane Bourreau; Matteo Rossi; Patrik Castiglioni; Remzi Onur Eren; Florence Prevel; Pierre Couppié; Suzanne M Hickerson; Pascal Launois; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  PLoS Pathog       Date:  2016-09-22       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.